Laurin Catherine, Labrecque Manon, Dupuis Gilles, Bacon Simon L, Cartier André, Lavoie Kim L
Department of Psychology, University of Québec at Montreal (UQAM), Canada.
Psychosom Med. 2009 Jul;71(6):667-74. doi: 10.1097/PSY.0b013e3181a82849. Epub 2009 Jun 26.
To assess prospectively the impact of psychiatric disorders on risk for exacerbations. The course of chronic obstructive pulmonary disease (COPD) is punctuated by acute exacerbations. Although anxiety and mood disorders are common in patients with COPD, no studies have assessed prospectively the association between these disorders and exacerbations.
Psychiatric disorders were evaluated by a structured psychiatric interview in 110 patients (51% women, age (mean +/- standard deviation) = 66 +/- 8 years) with stable COPD and previous admission for exacerbations recruited from two outpatient clinics. Patients were followed for a mean of 2 years and both inpatient-treated (i.e., treated in the emergency department or hospital) and outpatient-treated (i.e., treated with medication in the patient's own environment) exacerbations were recorded.
Independent of covariates, patients with psychiatric disorders exhibited a significantly higher weighted annual rate of exacerbations treated in an outpatient setting after adjustment for covariates (3 versus 2, p = .003) than patients without psychiatric disorders, but no difference in exacerbations treated in the inpatient setting. They were also at a higher risk for any (relative risk (RR) = 1.56, 95% Confidence Interval (CI) = 1.02-2.37) and outpatient (RR = 1.68, 95% CI = 1.08-2.59) exacerbations, but not inpatient exacerbations (RR = 1.36, 95% CI = 0.82-2.25).
Patients with psychiatric disorders are at greater risk of exacerbations treated in an outpatient setting but not those treated in an inpatient setting. These outpatient-managed exacerbations account for a significant proportion of the healthcare burden for COPD, so interventions should target patients with psychiatric disorders to improve management of COPD.
前瞻性评估精神障碍对病情加重风险的影响。慢性阻塞性肺疾病(COPD)病程中会不时出现急性加重。虽然焦虑和情绪障碍在COPD患者中很常见,但尚无研究前瞻性评估这些障碍与病情加重之间的关联。
对从两家门诊招募的110例稳定期COPD且曾因病情加重入院治疗的患者(51%为女性,年龄(均值±标准差)=66±8岁)进行结构化精神科访谈以评估精神障碍。患者平均随访2年,记录住院治疗(即在急诊科或医院治疗)和门诊治疗(即在患者自身环境中接受药物治疗)的病情加重情况。
独立于协变量因素,调整协变量后,有精神障碍的患者门诊治疗的加权年病情加重率显著高于无精神障碍的患者(分别为3次与2次,p = 0.003),但住院治疗的病情加重情况无差异。他们发生任何病情加重(相对风险(RR)=1.56,95%置信区间(CI)=1.02 - 2.37)和门诊病情加重(RR = 1.68,95%CI = 1.08 - 2.59)的风险也更高,但住院病情加重风险无差异(RR = 1.36,95%CI = 0.82 - 2.25)。
有精神障碍的患者门诊治疗病情加重的风险更高,但住院治疗病情加重的风险并非如此。这些门诊管理的病情加重占COPD医疗负担的很大一部分,因此干预措施应针对有精神障碍的患者以改善COPD的管理。